Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: We are missing a big piece to this puzzle - or

You say:

"If there was a business resolution to the J-3 dispute and/or there's settlement money that we're somehow not aware of, I don't think the officers would be allowed (under SEC regs) to purchase shares of Patriot if they have knowledge of this "positive" information."

IMO, that would be true IF there were absolute certainty that the money, in any amount, was definitely coming. If it were a contingency deal, or "business resolution", based on an outcome (e.g., USPTO) that is an "unknown"/not definite, then there would be no problem, IMO.

SGE

Share
New Message
Please login to post a reply